|
|
Bard Medical Division 8195 Industrial Boulevard
Covington
GA
30014
United States
770-784-6100
|
|
PRIVATE
|
Founded on a commitment to patient care, C. R. Bard is a worldwide leader in disease state management and is globally recognized for its tradition of quality, its commitment to clinical research and breakthrough products that advance the delivery of health care. It all began almost 100 years ago, when Charles Russell Bard began research for the treatment of urinary discomfort. This led to the development of the first balloon catheter in cooperation with Dr. Frederick E.B. Foley. Clinicians embraced the Foley Catheter, one of many innovations developed by C. R. Bard, Inc. The following are some of Bard’s historical highlights. 1907: Company founder, Charles R. Bard, begins importing GOMENOL to relieve urinary discomfort.
1923: C. R. Bard, Inc. formally incorporated.
1926: Charles R. Bard sells company to John F. Willits and Edson L. Outwin for $18,000.00.
1934: The first marketing of the Foley catheter.
1940: Bard begins distribution of the first American Woven Catheter.
1948: Headq
|
|
http://www.crbard.com/
|
|
|
|
|
|
|
|
|
|
BrachySource® I-125 Loose Seeds Product Literature
The BrachySource® iodine-125 implant is a combination of innovative design, consistently reliable dosimetry, and remarkable visibility that makes BrachySource® I-125 implant an ideal choice for your brachytherapy patients. You can be confident that every BrachySource® I-125 implant order is backed by our seed management services which is required by clinicians who must meet the time-critical demands of brachytherapy.
read more...
|
|
|
|
|
|
|